To further validate that RAS84 expression could predict high RAS activity in RAS mutants in individual cancers, we looked at pan-RAS mutation (KRAS, NRAS, HRAS) distributions across RI values per cohort (Supplementary Fig. 12d). The gene discussed is HRAS; the disease is cancer.